Source:http://linkedlifedata.com/resource/pubmed/id/12052918
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2002-6-7
|
pubmed:abstractText |
Recent technological breakthroughs allowing for large-scale analysis of gene transcripts and large-scale monitoring of the immune response with protein chips are revealing new participants in the pathogenesis of multiple sclerosis. Some of these participants may be useful targets for therapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0147-006X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
491-505
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12052918-Animals,
pubmed-meshheading:12052918-Central Nervous System,
pubmed-meshheading:12052918-Gene Expression Regulation,
pubmed-meshheading:12052918-Humans,
pubmed-meshheading:12052918-Inflammation Mediators,
pubmed-meshheading:12052918-Lymphocytes,
pubmed-meshheading:12052918-Multiple Sclerosis,
pubmed-meshheading:12052918-Myelin Sheath
|
pubmed:year |
2002
|
pubmed:articleTitle |
Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy.
|
pubmed:affiliation |
Department of Neurology and Neurological Sciences, Stanford University School of Medicine, California 94305, USA. steinman@stanford.edu
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Review,
Research Support, Non-U.S. Gov't
|